Move-PCD—a multi-center longitudinal randomized controlled superiority trial on the effect of a 6-month individualized supported physical activity (PA) program on quality of life (QoL) in children, adolescents, and adults with primary ciliary dyskine
German Clinical Trials Register (DRKS) 00033030. Registered on December 7, 2023. Update 10 July 2024. STUDY PROTOCOL VERSION 10: Version 1.2; 12 June 2024.
Authors
- Nina Timmesfeld (ORCID: https://orcid.org/0000-0002-5175-4326)
- Folke Brinkmann (ORCID: https://orcid.org/0000-0002-4307-4232)
- Anna Mai (ORCID: https://orcid.org/0000-0001-5600-8560)
- Marianne Tokic
- Anne Schlegtendal (ORCID: https://orcid.org/0000-0002-6737-3624)
- Anna Hoffmann (ORCID: https://orcid.org/0000-0002-8119-6070)
- Julien Stein (ORCID: https://orcid.org/0000-0002-9699-3240)
- Stefanie Dillenhöfer (ORCID: https://orcid.org/0000-0001-6020-8717)
- Christoph Maier (ORCID: https://orcid.org/0000-0003-1212-744X)
- Thomas Lücke
- Klaus Baum
Institutions
- University Hospitals of the Ruhr-University of Bochum (DE)
- LWL-Universitätsklinikum Bochum (DE)
- Ruhr University Bochum (DE)
Publication Details
- Journal
- Trials
- Published
- 2024-08-15
- DOI
- https://doi.org/10.1186/s13063-024-08379-0
- Citations
- 2
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.84